Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-09-020802
Filing Date
2009-04-15
Accepted
2009-04-15 17:12:53
Documents
16
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 v146247_10k.htm 10-K 4024847
2 GRAPHIC flowchart_pg06.jpg GRAPHIC 29346
3 GRAPHIC flowchart_pg13.jpg GRAPHIC 17479
4 GRAPHIC v146247_logo.jpg GRAPHIC 3293
5 GRAPHIC v146247_pg47.jpg GRAPHIC 54754
6 GRAPHIC v146247_pg5.jpg GRAPHIC 18310
7 GRAPHIC v146247_pg6.jpg GRAPHIC 23031
8 GRAPHIC v146247_pg7.jpg GRAPHIC 26465
9 GRAPHIC v146247_pg73.jpg GRAPHIC 33730
10 GRAPHIC v146247_pg74.jpg GRAPHIC 34921
11 GRAPHIC v146247_pg8.jpg GRAPHIC 35943
12 GRAPHIC v146247_revenuegraph.jpg GRAPHIC 23338
13 v146247_ex31-1.htm EX-31.1 13007
14 v146247_ex31-2.htm EX-31.2 13725
15 v146247_ex32-1.htm EX-32.1 11367
16 v146247_ex32-2.htm EX-32.2 10759
  Complete submission text file 0001144204-09-020802.txt   4491029
Mailing Address 65 NORWOOD AVENUE UPPER MONTCLAIR NJ 07043
Business Address 65 NORWOOD AVENUE UPPER MONTCLAIR NJ 07043 9737831117
Benda Pharmaceutical, Inc. (Filer) CIK: 0000705868 (see all company filings)

EIN.: 411419457 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16397 | Film No.: 09751880
SIC: 2834 Pharmaceutical Preparations